Teleconferência de Resultados do 3T 2026 da Nu Skin (NUS): Momentum do Prysm e Guidance Anual
A Nu Skin reportou receita de US$ 311 milhões e LPA ajustado de US$ 0,10 no terceiro trimestre de 2026, ambos em linha com as projeções. A margem operacional ajustada recuou para 3,7%, pressionada pelo mix de negócios entre o segmento principal e a Rhyz. A empresa destacou o avanço do dispositivo Prysm iO, cuja conversão de varredura para compra dobrou para 10% após a atualização 2.0. Para o quarto trimestre, a receita é estimada entre US$ 310 milhões e US$ 340 milhões. As prioridades estratégicas incluem o fortalecimento da força de vendas, o lançamento na Índia em 2027 e a eficiência operacional Leste-Oeste.
Principais destaques
- A Nu Skin (NYSE: NUS) reportou receita de US$ 311 milhões no 3T 2026 e LPA ajustado de US$ 0,10, ambos dentro das faixas de projeção da administração. O LPA reportado foi negativo em US$ 0,02.
- A margem operacional ajustada recuou de 5,9% no mesmo período do ano anterior para 3,7%. A margem bruta caiu para 65,0%, principalmente devido ao mix de receita entre o negócio principal da Nu Skin e os negócios da Rhyz.
- A plataforma de manufatura Rhyz apresentou forte crescimento anual de receita, enquanto o negócio principal continuou enfrentando pressão nas métricas de clientes e vendas.
- Aproximadamente 41.000 dispositivos Prysm iO haviam sido implementados globalmente até o fim do trimestre, gerando 4,5 milhões de varreduras. Após a atualização do aplicativo Prysm 2.0, a conversão de varredura para compra mais que dobrou, alcançando 10%.
- A Nu Skin projeta receita entre US$ 310 milhões e US$ 340 milhões no 4T e LPA ajustado de US$ 0,11 a US$ 0,21. A projeção de receita para o ano completo é de US$ 1,26 bilhão a US$ 1,29 bilhão, com LPA ajustado de US$ 0,55 a US$ 0,65.
- As prioridades da administração continuam sendo o avanço de sua plataforma antienvelhecimento, o fortalecimento das capacidades da força de vendas, a preparação para o lançamento formal na Índia no primeiro semestre de 2027 e a melhoria da eficiência por meio de um modelo operacional Leste-Oeste.
Principais dados financeiros
| Métrica | 3T 2026 | Comparação / Comentários |
|---|---|---|
| Receita | US$ 311 milhões | Incluiu um impacto cambial negativo de 1,1%, ou US$ 3,9 milhões |
| LPA reportado | -US$ 0,02 | Incluiu custos de transição organizacional e outros |
| LPA ajustado | US$ 0,10 | Dentro da faixa de projeção da administração |
| Margem bruta | 65,0% | Queda frente aos 70,5% do mesmo período do ano anterior, principalmente devido ao mix de negócios |
| Margem bruta do negócio principal da Nu Skin | 76,6% | Queda frente aos 77,7% |
| Despesas com vendas / receita | 33,2% | Queda frente aos 35,8% |
| Despesas com vendas / receita do negócio principal da Nu Skin | 40,9% | Queda frente aos 41,7%; a administração continua buscando a meta de cerca de 40% |
| Despesas gerais e administrativas (G&A) / receita | 30,2% | Em comparação com 28,8%; as despesas gerais e administrativas caíram US$ 10,9 milhões em relação ao ano anterior |
| Margem operacional ajustada | 3,7% | Queda frente aos 5,9% |
| Caixa e equivalentes de caixa | US$ 164,9 milhões | Saldo ao final do trimestre |
| Dívida total | US$ 203,7 milhões | Reduzida durante o trimestre |
| Dividendos pagos | US$ 2,9 milhões | Nenhuma ação foi recomprada |
| Autorização remanescente para recompra | US$ 137,3 milhões | Valor ao final do trimestre |
Desempenho operacional e dos negócios
O Prysm iO permaneceu no centro da estratégia de bem-estar personalizado da Nu Skin. A plataforma conecta varreduras de saúde nutricional, recomendações de produtos apoiadas por IA e uso recorrente de produtos. A administração informou que a atualização 2.0 do aplicativo, lançada no final de agosto, melhorou o engajamento dos clientes e mais que dobrou a conversão de varredura para compra, atingindo 10%.
O LifePak, principal suplemento nutricional da empresa, registrou crescimento de vendas de quase 3% em relação ao mesmo período do ano anterior no acumulado do ano. A administração citou isso como evidência do engajamento com sua plataforma de bem-estar, apesar da pressão sobre a receita mais ampla.
A plataforma de manufatura Rhyz registrou forte crescimento anual de receita durante o trimestre. No entanto, o negócio principal da Nu Skin continuou sofrendo pressão nas métricas gerais de clientes e força de vendas.
A Nu Skin está ajustando os incentivos da força de vendas e expandindo o desenvolvimento de lideranças. A administração afirmou que sua abordagem está migrando de promoções de curto prazo para remuneração, incentivos por metas e treinamentos projetados para melhorar a captação de clientes e afiliados. O treinamento está cada vez mais focado em mídias sociais, links atribuídos e transações digitais diretas.
A empresa continua se preparando para o lançamento formal na Índia no primeiro semestre de 2027. A administração afirmou que está refinando os planos operacionais, de produtos e comerciais após o período de pré-marketing, com ênfase na construção de uma base de mercado escalável.
A Nu Skin também está implementando uma estrutura operacional Leste-Oeste. A empresa espera um alinhamento mais próximo entre a manufatura e os mercados consumidores — utilizando os EUA para os mercados ocidentais e a China para os mercados orientais — para apoiar a margem bruta, a agilidade no lançamento de produtos e a otimização de custos fixos ao longo do tempo.
Projeções da administração
| Métrica da projeção | Perspectiva | Premissas relevantes |
|---|---|---|
| Receita do 4T 2026 | US$ 310 milhões–US$ 340 milhões | Inclui um impacto cambial positivo esperado de aproximadamente 1% |
| LPA reportado do 4T 2026 | US$ 0,05–US$ 0,15 | Inclui efeitos antecipados relacionados à transição |
| LPA ajustado do 4T 2026 | US$ 0,11–US$ 0,21 | Exclui custos especificados de transição organizacional |
| Receita do ano fiscal de 2026 | US$ 1,26 bilhão–US$ 1,29 bilhão | Inclui um impacto cambial negativo esperado de aproximadamente 1% |
| LPA reportado do ano fiscal de 2026 | -US$ 5,08 a -US$ 4,98 | Reflete a perda por impairment de ágio no 2T e a provisão para avaliação de tributos diferidos |
| LPA ajustado do ano fiscal de 2026 | US$ 0,55–US$ 0,65 | Exclui itens que não afetam o caixa, determinados encargos acumulados no ano e custos de transição previstos para o 4T |
| Alíquota efetiva de imposto ajustada | Aproximadamente 39% | Premissa para o ano completo após os ajustes declarados |
A administração antecipa crescimento sequencial da receita no 4T, impulsionado por esforços para elevar o engajamento de clientes e afiliados durante o período de festas de fim de ano. A empresa espera cerca de US$ 5 milhões em custos remanescentes de transição organizacional com desembolso de caixa no 4T; esses custos são excluídos da projeção de lucro ajustado.
Riscos e áreas de foco
- A receita do negócio principal e as métricas de clientes e da força de vendas continuam sob pressão.
- A rentabilidade é afetada pelo mix de receita entre o negócio principal da Nu Skin, de margem mais alta, e a Rhyz.
- A variação cambial reduziu a receita do 3T em US$ 3,9 milhões e deve continuar representando um impacto negativo de cerca de 1% no ano completo.
- A administração citou a inflação como um fator que afeta o orçamento dos clientes e a escolha de produtos.
- Os benefícios da estrutura Leste-Oeste, do realinhamento da manufatura e do desenvolvimento da força de vendas dependem da continuidade da execução e devem se consolidar ao longo do tempo.
- O aplicativo Prysm 2.0 permanece em estágio inicial, e a administração não forneceu uma meta específica de conversão para o médio prazo.
Destaques da sessão de perguntas e respostas com analistas
A administração afirmou que uma melhora sustentável no canal de vendas tem maior probabilidade de vir de mudanças no plano de remuneração, incentivos alinhados a metas e desenvolvimento de capacidades do que de promoções de curto prazo. A Nu Skin está adaptando os incentivos para equilibrar a captação de clientes e a formação de equipes enquanto prepara seu roteiro de incentivos para 2027.
Sobre o Prysm, a administração destacou que a taxa de conversão de 10% agrega diferentes tipos de varreduras, incluindo varreduras repetidas de assinantes atuais. O dispositivo tem o objetivo de apoiar tanto a captação quanto a retenção de clientes. A administração acredita que a conversão pode aumentar ainda mais à medida que o sistema de IA aprimorar sua compreensão das necessidades dos clientes e fornecer recomendações escalonadas de produtos com base em prioridades nutricionais e orçamentos, mas não estabeleceu uma meta numérica.
Transcrição completa da teleconferência de resultados
Transcrição completa da teleconferência de resultados
Comentários da administração
Operator
[Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, VP of Investor Relations, B.G. Hunt. Please go ahead.
B.G. Hunt
Thanks, Janelle, and good afternoon, everyone. I'm joined by Ryan Napierski, President and CEO, and by our interim CFO, Chelsea Lantz.
Today we'll be sharing Nu Skin's Q3 2026 results and providing guidance for the remainder of the year. Before I turn the time over to Ryan, let me point out that on today's call, comments will be made that include forward-looking statements. These statements involve important risks and uncertainties, and actual results may differ materially from those discussed or anticipated. Please refer to today's earnings release and our SEC filing for complete discussion of these risks. Also during the call, certain financial numbers may be discussed that differ from comparable numbers obtained in our financial statements. We believe these non-GAAP numbers assist in comparing period-to-period results in a more consistent manner. Please refer to our investor website, ir.nuskin.com, for any required reconciliation of these non-GAAP numbers. And with that, I'd like to now turn the call over to Ryan.
Ryan Napierski
Thanks, B.G. Good afternoon, everyone, and thanks for joining for our third quarter call. We delivered revenue of $311 million and adjusted EPS of $0.10, both within our guidance range. Our Rhyz manufacturing platform had an exceptional quarter, posting strong year-over-year revenue growth. While our results reflect ongoing pressures in the core business, we remain focused on our strategic priorities that we've outlined over the last year. Our Chief Operating Officer, Chayce Clark, has been leading the team to simplify, focus, and execute upon each of them. These priorities are: #1, advancing our integrated anti-aging platform; #2, strengthening our channel through improved sales force activation and development; #3, preparing for our formal launch of India early next year; and #4, improving our operating model to support greater profitability over time. Let me briefly update you on each of these priorities. So first, we continue to make progress in advancing our integrated anti-aging platform with Prysm iO playing an increasingly important role in our approach to personalized wellness.
Prysm is designed to help consumers better understand their nutritional health status and engage more consistently with our wellness product solutions, creating a differentiated experience that connects technology, products, and ongoing customer relationships. Since launching Prysm through the end of Q3, we've now placed approximately 41,000 devices globally and completed 4.5 million scans. During the quarter, we rolled out version 2.0 of the app, which delivers a meaningfully improved user experience powered by our new intelligent AI integration. Since the app update, we've more than doubled our scan-to-purchase conversion rate to 10%, which tells us that consumers are taking action when we get them more engaged with the platform. We also see this in demand for LifePak, our flagship nutritional supplement, as sales grew nearly 3% year-over-year year-to-date, a meaningful proof point given the broader revenue environment. We remain encouraged by the potential of this intelligent wellness platform to deepen customer engagement, support recurring product consumption, and provide our sales leaders with meaningful differentiation in the marketplace.
In September, we hosted our global Nu Skin Live convention in Yokohama, Japan with approximately 12,000 sales leaders from around the world. We previewed upcoming innovations in our anti-aging portfolio with a particular focus on women's health, which will begin rolling out mid-2027. We will share a future product pipeline with you as we move into next year. Second, we continue to invest in the capabilities necessary to strengthen our talented and committed global sales channel. We recognize that innovative products alone are not enough to drive sustainable growth. Equally important is our ability to empower our dedicated brand affiliates and sales leaders to effectively introduce our products, engage with our customers, and build successful businesses. Over the past several years, we've focused on improving the simplicity, accessibility, and effectiveness of our sales compensation incentive system.
We have also begun expanding our investments into leadership learning and development by providing unique opportunities for leaders to acquire and strengthen critical success capabilities in selling products, acquiring customers and brand affiliates, building sales teams, and leading large organizations. At Live, we held a dedicated live leadership training session with industry-renowned trainer Eric Worre and our Team Elite top sales leaders. We've also just wrapped up a two-day leadership management event, our Management Mastermind event earlier this week with nearly 2,000 of our most engaged sales leaders from around the globe. These investments are designed to further empower our talented sales leaders and strengthen their development of the next generation of leadership for Nu Skin. Although our overall customer and sales metrics remain under pressure, we believe these new investments are important to rebuilding engagement and productivity, which is the foundation for more sustainable performance in our channel into the future. Third, we continue to prepare for our anticipated formal launch of India during the first half of 2027. India represents an attractive long-term market opportunity supported by its large consumer population, growing interest in health and wellness, and an expanding entrepreneurial economy.
We've acquired many learning streams during our pre-marketing period and our teams are focused now on refining operational product and commercial preparations necessary to support a successful and scalable full market launch. We are approaching this opportunity with a long-term perspective as we focus on building the right foundation for sustainable growth. And finally, we remain focused on improving efficiency and profitability of our global business. As we continue to align our operations with current market conditions, we are evaluating opportunities to simplify our organization, improve productivity, and better leverage our global capabilities. Chayce is also leading an effort across the company to realign the organization around our East-West structure, which will enable the company to meet the unique needs of our business across these two hemispheres. Each region is now focused on building and executing successful go-to-market plans, including incentive roadmaps, product introductions, and promotions, in order to improve customer and affiliate acquisition and retention. We believe that aligning our organization around this East-West structure will also result in greater efficiencies and cost performance as we leverage our manufacturing hubs in both the U.S. for our western market needs and China to better serve our eastern markets.
Moving manufacturing closer to the customer is expected to improve gross margin, speed to market, and fixed cost optimization over time. While there is more work ahead, we believe disciplined execution against these priorities will help the company improve efficiencies and profitability as our business performance strengthens. Looking ahead to the fourth quarter, our focus remains on driving customer and affiliate engagement through the holiday seasons as we anticipate sequential revenue growth. As we prepare for 2027, we remain committed to the strategic priorities we've outlined throughout the year: again, advancing our anti-aging platform, strengthening our sales channel, preparing for India's formal launch, and improving our operating efficiency. We believe these initiatives position Nu Skin for improved performance and sustainable growth long-term. So with that, I'll turn the time over to Chelsea to review our financials.
Chelsea Lantz
Thanks, Ryan. Good afternoon, everyone. Today I'll review our third quarter results and discuss our outlook for the remainder of the year. Third quarter revenue was $311 million within the guidance range, including an approximate 1.1% or $3.9 million foreign currency headwind. Reported earnings per share were negative $0.02 or a positive $0.10, excluding organizational transition costs related to the implementation of our ERP, East-West operating model, and certain other charges. Adjusted earnings per share were in line with our guidance range. Gross margin for the quarter was 65% compared to 70.5% in the prior year, primarily reflecting the revenue mix between our Nu Skin core and Rhyz businesses. Within the core Nu Skin business, gross margin was 76.6% compared to 77.7% in the prior year. We remain committed to our gross margin improvement initiatives through pricing discipline, product mix optimization, and operational efficiencies within the core business.
Selling expense as a percentage of revenue was 33.2% compared to 35.8% in the prior year. Within the core Nu Skin business, selling expense was 40.9% compared to 41.7% in the prior year. We continue to target core selling expense around 40%. General and administrative expenses declined by $10.9 million year-over-year to 30.2% of revenue compared to 28.8% in the prior year. As we continue to right-size our fixed cost base to current operations while preserving investment in key strategic priorities. Adjusted operating margin for the quarter was 3.7% compared to 5.9% in the prior year. We continue to make progress on the implementation of the East-West operating model announced last quarter to better align our resources with the needs of our markets. We currently anticipate approximately $5 million in remaining cash-based organizational transition costs in the fourth quarter, which have been excluded from our adjusted earnings guidance.
On the balance sheet, we ended the quarter with $164.9 million of cash and cash equivalents and reduced our total debt to $203.7 million. We remain focused on disciplined capital allocation and returned $2.9 million to shareholders through dividends during the quarter. We did not repurchase shares, leaving $137.3 million remaining under our current authorization. Turning to our outlook for the fourth quarter and full year. For the fourth quarter, we expect revenue in the range of $310 million to $340 million, including an anticipated foreign currency tailwind of approximately 1%. We expect reported earnings per share in the range of $0.05 to $0.15 or adjusted earnings per share of $0.11 to $0.21. For the full year, we now expect revenue of $1.26 billion to $1.29 billion, including an anticipated foreign currency headwind of approximately 1%.
We expect annual reported earnings per share of negative $5.08 to negative $4.98, reflecting the impact of the second quarter goodwill impairment and deferred tax valuation allowance, which did not affect our cash position or ability to execute on our strategic plan. On an adjusted basis, we expect annual earnings per share of $0.55 to $0.65, excluding these non-cash items, certain other year-to-date charges, and anticipated fourth quarter organizational transition costs. After these adjustments, our guidance reflects an effective tax rate for the year of approximately 39%. As discussed today, we are taking deliberate steps to strengthen the business from optimizing our cost structure to evolving our operating model. Our focus remains on disciplined execution and improving profitability, and we're confident these actions will position us for sustainable growth in the periods ahead. With that, operator, we'll now open the line for questions.
Operator
[Operator Instructions]
Our first question comes from the line of Dave Storms with StoneGate.
Perguntas e respostas
David Storms
I know you guys are busy between India and Prysm, so I'll try to be brief here. Just a couple. Ryan, when you were talking about strengthening the sales channel and obviously trying to grow the customer base, I recognize that sometimes the customer base can follow the leaders, leaders can follow the customers, a bit of a push and pull there. Are there any incentives to highlight here that might bring that back beyond what you talked about with all the leadership initiatives that you have?
Ryan Napierski
Yes, so a lot of the leadership initiatives, Dave, that we are focused on are really around how do we enhance the customer acquisition and brand affiliate acquisition, and that really is the focus for us. As we have learned over the course of the last few years, incentives and short-term promotions are not as helpful at building channel momentum as more of a sustained programmatic approach. So when I mention kind of the three levers, you have the compensation system itself, the incentive roadmap that layers on top of that, that kind of recognizes and rewards key development. Those have kind of been our two levers that we've been really working to ensure that they're right for the market. So some compensation plan enhancements have been rolling around the world over the course of this past year to right-size the incentives for customer acquisition versus team building, for instance. And then we've been working, especially in the second half, to realign our incentive roadmap, again, these key milestone areas, to ensure that those are fully aligned for the 2027 year. This third piece though that we're talking about really is this learning and development platform that we're talking about for our leadership.
And it really is focusing on core skills and capabilities that are needed in the market, and a lot of that is related to just the changes in the marketplace over the course of the last 5 to 10 years. Today, the way that our affiliates build the business in terms of sharing products on social media, posting, sharing, commenting, DMing, that's a very different set of skills and capabilities than the way they used to do the job, what we used to call them distributors, where they would buy products wholesale and sell those. So the vast majority of our customers today transact on our platform directly through links, attributed links through social media, etc. And so we've realized that these skills, these capabilities, and the shift—and it's very different by market, different markets at different stages—but that's really where we need to focus: less on the short term, more on the systemic and sustainable skills and capabilities.
Chelsea Lantz
I would just add, and I said in my prepared remarks, but as we look at these changes and balancing our approach from a strategic standpoint, we do feel like 40% is the right level from a cost perspective. So that's how we're modeling it in our models for the core business.
David Storms
Understood. That's great. I appreciate that. And then just did want to maybe get a temperature check on Prysm. I know we've talked in the past about—I appreciate the new commentary around 10% scan-to-purchase conversion rate. Add in, you know, version 2.0 app, it sounds like there's a lot of tailwinds there. I think honing in on the conversion rate, how should we think about the success? I mean, is 10% just getting started, or what you would expect to see in the medium term? Just any thoughts there.
Ryan Napierski
Yes, no, I mean it's pretty interesting. So as I mentioned, if we just kind of do the simple math—and you'll have to do it for me here—4.5 million scans over 41,000 units. We're talking about many scans per unit that we are seeing. Some of that is self-scanning, others guest scanning, so we kind of are tracking all of this data differently. The 10% really is kind of an aggregation of that process. And so I think there's a lot of room for improved conversion when you think of the total scans.
But this device is unique because it plays a role for both acquiring new customers as well as retaining customers on the device. So, for example, I scan myself twice a week. I'm already on a subscription, right? And so obviously my conversion with each of my scans and such, that's not driving that 10% rate. I really do believe, and we're still in the early stage of this, what we have learned with the 2.0 and this new intelligent AI, the increased interactivity between the app and the customer with respect to their personalized product recommendation and the insights they gather through that AI algorithmic approach is really creating a greater engagement level. We are happy to see—we're very early, I think 2.0 rolled out the latter part of August, last week of August, so we're really talking about kind of a doubling within a month's time. And I think there's room upwards. I don't know that I could give you an exact number, but we certainly haven't hit the top there. I would hope to see that that can increase significantly from there, the smarter that intelligence gets in understanding that customer's needs and kind of helping them navigate which product solution set—kind of we do a good, better, best recommendation—which set is going to best meet their needs. And those needs also, by the way, include their pocketbook.
Obviously, inflation is heavy right now. Our app does look in kind of a good, better, best scenario to say where is the essential nutrition that you need versus kind of a more extensive and then optimal level. So we do try to give consumer choices to play into that.
David Storms
That's great, [ Carl ]. I really appreciate that. That's all I have. I appreciate the time, and good luck in the next quarter.
B.G. Hunt
All right, thanks, Dave.
Operator
I'm showing no further questions at this time. I would now like to turn the conference back to President and CEO Ryan Napierski for closing remarks.
Ryan Napierski
Well, truly, you know, we're in the day-to-day here at Nu Skin working with our sales leaders around the world, our teams in nearly 50 markets around the world. And it's always interesting to me when we get to go interact with this team and our teams and to see the dedication of our employees around the world, the dedication of our sales leaders to the mission of this company to be a global force for good by empowering people to look, feel, and live better. And they feel this truly to their bones, and it's just very inspiring to me. Our mission is absolutely needed in the world today. We're absolutely committed to delivering it, to leveraging technology to do it better through our sales force, who is ultimately the key to our success. And so with that, we'll plan to keep you updated quarter to quarter as our journey continues.
And we thank you for your support and your ongoing interest as we move forward. Thank you, everybody.
Operator
Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.
This live transcript is auto-generated without human intervention or review.
Este artigo pode conter conteúdo gerado ou traduzido por IA, revisado por humanos, destinado apenas para referência e informações gerais, não constituindo recomendação de investimento.
Artigos recomendados







Comentários (0)
Clique no botão $, digite o código do ativo e selecione para vincular uma ação, ETF ou outro ticker.